Dan Leonard
Stock Analyst at UBS
(4.00)
# 583
Out of 4,496 analysts
212
Total ratings
56.52%
Success rate
8.83%
Average return
Main Sectors:
30 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BIO.B Bio-Rad Laboratories | Maintains: Buy | $420 → $385 | $294.23 | +30.85% | 16 | May 8, 2024 | |
| BIO Bio-Rad Laboratories | Maintains: Buy | $420 → $385 | $296.82 | +29.71% | 16 | May 8, 2024 | |
| TXG 10x Genomics | Maintains: Neutral | $52 → $30 | $16.70 | +79.64% | 1 | May 1, 2024 | |
| RHP Ryman Hospitality Properties | Maintains: Overweight | $125 → $133 | $102.53 | +29.72% | 3 | Mar 21, 2024 | |
| CERT Certara | Maintains: Neutral | $17 → $20 | $16.08 | +24.38% | 7 | Mar 1, 2024 | |
| RVTY Revvity | Downgrades: Neutral | $105 → $125 | $108.15 | +15.58% | 1 | Jan 16, 2024 | |
| TECH Bio-Techne | Initiates: Buy | $80 | $75.46 | +6.02% | 9 | Dec 7, 2023 | |
| FLGT Fulgent Genetics | Initiates: Neutral | $35 | $21.82 | +60.40% | 4 | Dec 7, 2023 | |
| A Agilent Technologies | Maintains: Outperform | $160 → $150 | $131.78 | +13.83% | 16 | Aug 16, 2023 | |
| ILMN Illumina | Maintains: Neutral | $225 → $200 | $114.49 | +74.69% | 10 | Aug 10, 2023 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Neutral | $14 → $11 | $8.64 | +27.31% | 6 | Aug 8, 2023 | |
| NTRA Natera | Reiterates: Outperform | $70 | $105.98 | -33.95% | 7 | Aug 4, 2023 | |
| EXAS Exact Sciences | Maintains: Neutral | $75 → $90 | $46.81 | +92.27% | 9 | Aug 2, 2023 | |
| AVTR Avantor | Reiterates: Neutral | $24 | $20.85 | +15.11% | 5 | Jul 31, 2023 | |
| TMO Thermo Fisher | Upgrades: Outperform | $620 | $534.35 | +16.03% | 10 | Jul 13, 2023 | |
| CRL Charles River Laboratories International | Maintains: Outperform | $260 → $255 | $218.24 | +16.84% | 5 | May 12, 2023 | |
| GH Guardant Health | Maintains: Outperform | $60 → $55 | $30.75 | +78.86% | 7 | May 10, 2023 | |
| DHR Danaher | Maintains: Neutral | $300 → $270 | $243.54 | +10.86% | 11 | Apr 26, 2023 | |
| ADPT Adaptive Biotechnologies | Reiterates: Underperform | $7 | $4.04 | +73.27% | 2 | Feb 15, 2023 | |
| IQV IQVIA Holdings | Reiterates: Outperform | $265 | $224.57 | +18.00% | 6 | Feb 13, 2023 | |
| WAT Waters | Initiates: Neutral | $345 | $302.72 | +13.97% | 8 | Aug 25, 2022 | |
| ICLR ICON PLC | Initiates: Neutral | $260 | $329.70 | -21.14% | 5 | Aug 25, 2022 | |
| DGX Quest Diagnostics | Maintains: Equal-Weight | $160 → $145 | $146.01 | -0.69% | 9 | Feb 4, 2022 | |
| HOLX Hologic | Maintains: Overweight | $95 → $90 | $78.11 | +15.22% | 10 | Feb 3, 2022 | |
| QGEN Qiagen | Maintains: Equal-Weight | $60 → $62 | $41.55 | +48.74% | 2 | Dec 14, 2021 | |
| LH Labcorp Holdings | Maintains: Overweight | n/a | $211.37 | - | 7 | Dec 14, 2021 | |
| BRKR Bruker | Maintains: Equal-Weight | n/a | $61.89 | - | 6 | Nov 2, 2021 | |
| STVN Stevanato Group | Initiates: Overweight | n/a | $21.38 | - | 1 | Aug 10, 2021 | |
| MTD Mettler-Toledo International | Maintains: Equal-Weight | n/a | $1,344.26 | - | 6 | Jul 30, 2021 | |
| MYGN Myriad Genetics | Maintains: Hold | n/a | $25.97 | - | 7 | Nov 5, 2018 |
Bio-Rad Laboratories
May 8, 2024
Maintains: Buy
Price Target: $420 → $385
Current: $294.23
Upside: +30.85%
Bio-Rad Laboratories
May 8, 2024
Maintains: Buy
Price Target: $420 → $385
Current: $296.82
Upside: +29.71%
10x Genomics
May 1, 2024
Maintains: Neutral
Price Target: $52 → $30
Current: $16.70
Upside: +79.64%
Ryman Hospitality Properties
Mar 21, 2024
Maintains: Overweight
Price Target: $125 → $133
Current: $102.53
Upside: +29.72%
Certara
Mar 1, 2024
Maintains: Neutral
Price Target: $17 → $20
Current: $16.08
Upside: +24.38%
Revvity
Jan 16, 2024
Downgrades: Neutral
Price Target: $105 → $125
Current: $108.15
Upside: +15.58%
Bio-Techne
Dec 7, 2023
Initiates: Buy
Price Target: $80
Current: $75.46
Upside: +6.02%
Fulgent Genetics
Dec 7, 2023
Initiates: Neutral
Price Target: $35
Current: $21.82
Upside: +60.40%
Agilent Technologies
Aug 16, 2023
Maintains: Outperform
Price Target: $160 → $150
Current: $131.78
Upside: +13.83%
Illumina
Aug 10, 2023
Maintains: Neutral
Price Target: $225 → $200
Current: $114.49
Upside: +74.69%
Maravai LifeSciences Holdings
Aug 8, 2023
Maintains: Neutral
Price Target: $14 → $11
Current: $8.64
Upside: +27.31%
Natera
Aug 4, 2023
Reiterates: Outperform
Price Target: $70
Current: $105.98
Upside: -33.95%
Exact Sciences
Aug 2, 2023
Maintains: Neutral
Price Target: $75 → $90
Current: $46.81
Upside: +92.27%
Avantor
Jul 31, 2023
Reiterates: Neutral
Price Target: $24
Current: $20.85
Upside: +15.11%
Thermo Fisher
Jul 13, 2023
Upgrades: Outperform
Price Target: $620
Current: $534.35
Upside: +16.03%
Charles River Laboratories International
May 12, 2023
Maintains: Outperform
Price Target: $260 → $255
Current: $218.24
Upside: +16.84%
Guardant Health
May 10, 2023
Maintains: Outperform
Price Target: $60 → $55
Current: $30.75
Upside: +78.86%
Danaher
Apr 26, 2023
Maintains: Neutral
Price Target: $300 → $270
Current: $243.54
Upside: +10.86%
Adaptive Biotechnologies
Feb 15, 2023
Reiterates: Underperform
Price Target: $7
Current: $4.04
Upside: +73.27%
IQVIA Holdings
Feb 13, 2023
Reiterates: Outperform
Price Target: $265
Current: $224.57
Upside: +18.00%
Waters
Aug 25, 2022
Initiates: Neutral
Price Target: $345
Current: $302.72
Upside: +13.97%
ICON PLC
Aug 25, 2022
Initiates: Neutral
Price Target: $260
Current: $329.70
Upside: -21.14%
Quest Diagnostics
Feb 4, 2022
Maintains: Equal-Weight
Price Target: $160 → $145
Current: $146.01
Upside: -0.69%
Hologic
Feb 3, 2022
Maintains: Overweight
Price Target: $95 → $90
Current: $78.11
Upside: +15.22%
Qiagen
Dec 14, 2021
Maintains: Equal-Weight
Price Target: $60 → $62
Current: $41.55
Upside: +48.74%
Labcorp Holdings
Dec 14, 2021
Maintains: Overweight
Price Target: n/a
Current: $211.37
Upside: -
Bruker
Nov 2, 2021
Maintains: Equal-Weight
Price Target: n/a
Current: $61.89
Upside: -
Stevanato Group
Aug 10, 2021
Initiates: Overweight
Price Target: n/a
Current: $21.38
Upside: -
Mettler-Toledo International
Jul 30, 2021
Maintains: Equal-Weight
Price Target: n/a
Current: $1,344.26
Upside: -
Myriad Genetics
Nov 5, 2018
Maintains: Hold
Price Target: n/a
Current: $25.97
Upside: -